ArticleACS medicinal chemistry letters2019

Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary Cirrhosis.

Zhigan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.